PXN-AS1
gene geneOn this page
Also known as EyeLinc4
Summary
PXN-AS1 (PXN antisense RNA 1, HGNC:44123) is a long non-coding RNA gene on chromosome 12q24.23.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44123 |
| Approved symbol | PXN-AS1 |
| Name | PXN antisense RNA 1 |
| Location | 12q24.23 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | EyeLinc4 |
| Ensembl gene | ENSG00000255857 |
| Ensembl biotype | lncRNA |
| Entrez | 100506649 |
| RNAcentral | URS000075E544 — lncRNA, 778 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 16 lncRNA
ENST00000535200, ENST00000538804, ENST00000539446, ENST00000542265, ENST00000542314, ENST00000620336, ENST00000664264, ENST00000667017, ENST00000667721, ENST00000684870, ENST00000693683, ENST00000693713, ENST00000702713, ENST00000826986, ENST00000826987, ENST00000826988
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000535200 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002266194 | 120210930 | 120211106 |
| ENSE00002279375 | 120209839 | 120209934 |
| ENSE00002290624 | 120206545 | 120206621 |
| ENSE00004238410 | 120201311 | 120201426 |
| ENSE00004238412 | 120212375 | 120213138 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 85.91.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.0642 / max 41.1192, expressed in 1610 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 128321 | 2.4528 | 1132 |
| 128319 | 2.2976 | 918 |
| 128322 | 0.6853 | 414 |
| 128320 | 0.6285 | 395 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.91 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 85.43 | gold quality |
| monocyte | CL:0000576 | 85.19 | gold quality |
| leukocyte | CL:0000738 | 85.08 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.13 | gold quality |
| sural nerve | UBERON:0015488 | 84.02 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.34 | gold quality |
| granulocyte | CL:0000094 | 83.05 | gold quality |
| rectum | UBERON:0001052 | 82.42 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 82.35 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 82.19 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 81.78 | gold quality |
| tibial nerve | UBERON:0001323 | 81.46 | gold quality |
| right ovary | UBERON:0002118 | 80.56 | gold quality |
| right uterine tube | UBERON:0001302 | 80.31 | gold quality |
| adenohypophysis | UBERON:0002196 | 80.00 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 79.95 | gold quality |
| gastrocnemius | UBERON:0001388 | 79.81 | gold quality |
| left ovary | UBERON:0002119 | 79.71 | gold quality |
| right lobe of liver | UBERON:0001114 | 79.69 | gold quality |
| muscle of leg | UBERON:0001383 | 79.65 | gold quality |
| ventricular zone | UBERON:0003053 | 79.60 | gold quality |
| skin of leg | UBERON:0001511 | 79.50 | gold quality |
| colonic epithelium | UBERON:0000397 | 79.35 | gold quality |
| ectocervix | UBERON:0012249 | 79.25 | gold quality |
| skin of abdomen | UBERON:0001416 | 79.21 | gold quality |
| left uterine tube | UBERON:0001303 | 79.18 | gold quality |
| pancreas | UBERON:0001264 | 78.85 | gold quality |
| spinal cord | UBERON:0002240 | 78.46 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 78.38 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9543 | yes | 10.72 |
| E-ANND-3 | yes | 5.15 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- LncRNA PXN-AS1-L isoform is upregulated in nasopharyngeal carcinoma (NPC) and associated with poor prognosis. PXN-AS1-L promotes NPC cell proliferation, migration, and invasion in vitro, and NPC tumor growth in vivo. PXN-AS1-L directly interacts with SAPCD2 mRNA 3’UTR, and upregulates its mRNA and protein expression. (PMID:31173488)
- PXN-AS1 functioned as a sponge to suppress the expression of miR-3064. (PMID:31488171)
- Upregulation of lncRNA PXN-AS1-L is associated with unfavorable prognosis in patients suffering from glioma. (PMID:31696482)
- SOX9-activated PXN-AS1 promotes the tumorigenesis of glioblastoma by EZH2-mediated methylation of DKK1. (PMID:32329150)
- DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis. (PMID:34626132)
- Upregulation of MAPKAPK5-AS1, PXN-AS1 and URB1-AS1 lncRNAs in non-functioning pituitary adenoma. (PMID:37154079)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.